or
forgot password
  • cancer clinical trials in boston, MA

  • Combination Chemotherapy, Radiation Therapy and Surgery for Esophageal Cancer
    Massachusetts General Hospital
    Boston, Massachusetts 02114-2617
    Adenocarcinoma of Esophagus, Squamous Cell Carcinoma of Esophagus
    Pleurectomy/Decortication With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Sodium Thiosulfate
    Dana-Farber Cancer Institute

    Trial Locations
    Dana-Farber Cancer Institute
    Brigham and Women's Hospital
    Pleural Mesothelioma, Malignant Pleural Mesothelioma
    A-Protein Levels in Adult and Pediatric Brain Tumor Patients
    Dana Farber Cancer Institite
    Boston, Massachusetts 02115
    Malignant or Benign Lesions of the Central Nervous System
    Pleurectomy/Decortication Followed by Intrathoracic/Intraperitoneal Heated Cisplatin for Malignant Pleural Mesothelioma
    Dana-Farber Cancer Institute

    Trial Locations
    Dana-Farber Cancer Institute
    Brigham and Women's Hospital
    Pleural Mesothelioma, Malignant Pleural Mesothelioma
    An Extension Study of the Safety and Anti-leukemic Effects of Imatinib Mesylate in Adult Patients With Ph + Leukemia
    Dana Faber Cancer Institute
    Boston, Massachusetts 02115
    Philadelphia Positive Chronic Myeloid Leukemia in Accelerated Phase, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
    An Extension Study of the Safety and Anti-leukemic Effects of Imatinib Mesylate in Adult Patients With Ph + Leukemia
    Dana Faber Cancer Institute
    Boston, Massachusetts 02115
    Philadelphia Positive Chronic Myeloid Leukemia in Accelerated Phase, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
    Study of Long-Term Peg Intron Vs. Colchicine in Non-Responders.
    Beth Israel Deaconess Medical Center
    Boston, Massachusetts 02215
    Hepatitis C Virus, Advanced Fibrosis, Cirrhosis
    Acute Myeloid Leukemia T Cell Depletion to Improve Transplants in Adults With Acute Myeloid Leukemia
    Dana Farber Cancer Institute/Brigham & Women's Hospital
    Boston, Massachusetts 02114
    Leukemia, Myelocytic, Acute
    Study of Complementary Therapies in Men Receiving Radiation Therapy for Prostate Cancer: A Feasibility Trial
    Brigham and Women's Hospital
    Boston, Massachusetts 02115
    Prostate Cancer
    Neurosurgical Use of Interstitial Laser Therapy (ILT)
    Brigham & Women's Hospital
    Boston, Massachusetts 02115
    Brain Tumor
    A Study of ONTAK and CHOP in Newly Diagnosed, Peripheral T-Cell Lymphoma
    New England Medical Center

    Trial Locations
    New England Medical Center
    Dana Farber/ Harvard Cancer Center
    Lymphoma, T-Cell, Peripheral
    Adjuvant Chemoradiation Therapy for Gastric or Gastroesophageal Junction Adenocarcinoma
    Dana-Farber Cancer Institute

    Trial Locations
    Dana-Farber Cancer Institute
    Brigham and Women's Hospital
    Massachusetts General Hospital
    Stomach Cancer, Gastric Cancer, Gastro-esophageal Junction Cancer
    A Safety Study of Rituximab Plus MTX Injected Into the Cerebrospinal Fluid in the Treatment of Brain Lymphoma
    Massachusetts General Hospital
    Boston, Massachusetts 02114-2617
    Central Nervous System Lymphoma, Intraocular Lymphoma
    Primary Care Physicians' Use of Stop-Smoking Plans to Help Patients Who Are Smokers
    Massachusetts General Hospital Cancer Center

    Trial Locations
    Massachusetts General Hospital Cancer Center
    Harvard Pilgrim Health Care
    Tobacco Use Disorder, Unspecified Adult Solid Tumor, Protocol Specific
    A Study of the Efficacy and Safety of Imatinib Mesylate in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing C-kit Gene
    Dana Farber Cancer Institute Dept of Sarcoma Oncology
    Boston, Massachusetts 02115
    Unresectable or Metastatic Malignant Gastrointestinal Stromal Tumor (GIST)
    Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
    Beth Israel Deaconess Medical Center

    Trial Locations
    Beth Israel Deaconess Medical Center
    Massachusetts General Hospital Cancer Center
    Boston Medical Center
    Stage I Bladder Cancer, Stage II Bladder Cancer, Stage III Bladder Cancer, Transitional Cell Carcinoma of the Bladder
    Gemcitabine, 5-Fluorouracil, and Radiation Therapy in the Treatment of Non-Metastatic Pancreatic Cancer
    Brigham and Women's Hospital

    Trial Locations
    Brigham and Women's Hospital
    Massachusetts General Hospital
    Pancreatic Cancer
    N2001-02: I-Metaiodobenzylguanidine (MIBG) With Intensive Chemotherapy and Autologous Stem Cell Rescue for High-Risk Neuroblastoma
    Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute
    Boston, Massachusetts 02115
    Neuroblastoma
    Massage Therapy in Treating the Symptoms of Patients With Locally Advanced or Metastatic Cancer
    Beth Israel Deaconess Medical Center
    Boston, Massachusetts 02215
    Cancer
    A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS)
    Dana Farber Cancer Institute

    Trial Locations
    Dana Farber Cancer Institute
    Caritas St. Elizabeth Med Ctr
    Non-Small Cell Lung Cancer
    Bortezomib and Gemcitabine Hydrochloride in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
    Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute
    Boston, Massachusetts 02115
    Lymphoma
    Real-Time Image Guided Lymphatic Mapping and Nodal Targeting in Lung Cancer
    Beth Israel Deaconess Medical Center

    Trial Locations
    Beth Israel Deaconess Medical Center
    Dana-Farber Cancer Institute
    Brigham and Women's Hospital
    Lung Cancer
    Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
    Massachusetts General Hospital

    Trial Locations
    Massachusetts General Hospital
    Dana-Farber/Brigham and Women's Cancer Center
    Boston University Cancer Research Center
    Colorectal Cancer
    Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas
    Dana-Farber Cancer Institute
    Boston, Massachusetts 02115
    Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Adult Mixed Glioma, Recurrent Adult Brain Tumor
    Study to Assess Compliance With Long-Term Mercaptopurine Treatment in Young Patients With Acute Lymphoblastic Leukemia in Remission
    Floating Hospital for Children at Tufts - New England Medical Center
    Boston, Massachusetts 02111
    Leukemia
    Letrozole in Postmenopausal Women at Increased Risk for Breast Cancer
    Beth Israel Deaconess Medical Center

    Trial Locations
    Beth Israel Deaconess Medical Center
    Dana-Farber Cancer Institute
    Massachusetts General Hospital
    Post-Menopausal, Breast Cancer
    Fenretinide LXS in Treating Patients With Recurrent, Refractory, or Persistent Neuroblastoma
    Children's Hospital Boston
    Boston, Massachusetts 02115
    Neuroblastoma
    Study of Amiodarone Given Before Lung Surgery to Prevent Atrial Fibrillation After Lung Resection
    Beth Israel Deaconess Medical Center
    Boston, Massachusetts 02215
    Atrial Fibrillation, Lung Cancer
    Study Evaluating HKI-272 (Neratinib) In Subjects With Advanced Breast Cancer
    Investigational Site
    Boston, Massachusetts 02118
    Breast Neoplasms, Neoplasms
    Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer
    Beth Israel Deaconess Medical Center
    Boston, Massachusetts 02215
    Kidney Cancer
    Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor
    Dana-Farber Cancer Institute
    Boston, Massachusetts 02115
    Stage I Adrenocortical Carcinoma, Stage II Adrenocortical Carcinoma, Stage III Adrenocortical Carcinoma, Stage IV Adrenocortical Carcinoma
    A Study to Evaluate RAF265, an Oral Drug Administered to Subjects With Locally Advanced or Metastatic Melanoma
    Massachusetts General Hospital Dept of Cancer for Melanoma

    Trial Locations
    Massachusetts General Hospital Dept of Cancer for Melanoma
    Dana Farber Cancer Institute DFCI
    Metastatic Melanoma